Pasi A Janne

61PUBLICATIONS
659CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Jul 06, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.

|Apr 28, 2026
The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with KRAS Mutation-Positive Solid Tumors.

|Dec 05, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.

Sara A Walton, Justin J Kim, Francesco Paoloni

Pageof 11

Frequent Collaborators

12 joint publications

Lynette M Sholl

8 joint publications

Prafulla Gokhale

8 joint publications

James Chih-Hsin Yang

8 joint publications

Melissa L Johnson